Wave Life Sciences WVE
NASDAQ WVE
$4.85 +0.15 (+3.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Wave Life Sciences (WVE) Other Accumulated Expenses (2014 - 2017)

Wave Life Sciences' (WVE) quarterly Other Accumulated Expenses came in at $156000.0 in Q4 2017, down 83.54% YoY from $948000.0 in Q4 2016, and down 83.54% on a QoQ basis from $948000.0 in Q4 2016.

Analysis

Wave Life Sciences (WVE) Other Accumulated Expenses (2014 - 2017) Analysis & Trends

Wave Life Sciences (WVE) has 4 years of Other Accumulated Expenses data on file, last reported at $156000.0 in Q4 2017.

  • Quarterly Other Accumulated Expenses fell 83.54% year-over-year to $156000.0 in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $156000.0 (down 83.54% YoY) and the FY2017 annual result came in at $156000.0, down 83.54% from the prior year.
  • Other Accumulated Expenses fell to $156000.0 in Q4 2017, from $948000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $948000.0 in Q4 2016 to a low of $156000.0 in Q4 2017.
  • A 4-year average of $408000.0 and a median of $353000.0 in 2015 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2016 — Other Accumulated Expenses soared 168.56% — and 2017, when it sank 83.54%.
  • Tracing WVE's Other Accumulated Expenses over 4 years: stood at $177000.0 in 2014, then jumped by 99.44% to $353000.0 in 2015, then soared by 168.56% to $948000.0 in 2016, then slumped by 83.54% to $156000.0 in 2017.
  • The last three Other Accumulated Expenses figures came in at $156000.0 (Q4 2017), $948000.0 (Q4 2016), and $353000.0 (Q4 2015), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Wave Life Sciences 994.54 Mn 626.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 156,000.00
Dec 31, 2016 948,000.00
Dec 31, 2015 353,000.00
Sep 30, 2015 406,000.00
Dec 31, 2014 177,000.00